Abstract
Dyspepsia and Helicobacter pylori infection are two important public health issues in the field of gastroenterology, generating high expenditures in diagnosis and treatment. A causal relationship between H. pylori and dyspepsia is still debated. The aim of this study was to address changes in the prevalence of, and association between, dyspepsia and H. pylori infection in a general population. The study took place in the municipality of Sørreisa in Northern Norway. Data were collected in 1987 and 2004. The study included questionnaires on gastrointestinal disorders and risk factors, as well as H. pylori assessment. The prevalence of dyspepsia in 2004 was 31.9% in men and 31.7% in women (compared with 30.7 and 26.3% in 1987). In 2004, the prevalence of H. pylori infection in men with/without dyspepsia was 20.3/26.7% (compared with 47.0/32.7% in 1987), whereas the prevalence of H. pylori infection in women with/without dyspepsia was 31.3/20.8% (compared with 50.0/40.7% in 1987). Since 1987, the prevalence of H. pylori has decreased independently of dyspepsia, most pronounced in the younger age groups, thus indicating a cohort effect. Our findings of a decreasing prevalence of H. pylori, a persistently high prevalence of dyspepsia, and an uneven distribution of H. pylori infection with regard to dyspepsia in men and women, question the understanding of a causal relationship between dyspepsia and H. pylori.
Similar content being viewed by others
Abbreviations
- CI:
-
Confidence interval
- ELISA:
-
Enzyme linked immunosorbent assay
- GEE:
-
Generalised estimating equations
- GSRS:
-
Gastrointestinal symptoms rating scale
- H. pylori :
-
Helicobacter pylori
- κ:
-
Kappa
- WHO:
-
World Health Organisation
References
Tebaldi M, Heading RC. Clinical economics review: functional (non-ulcer) dyspepsia. Aliment Pharmacol Ther. 1998;12:11–9. doi:10.1046/j.1365-2036.1998.00261.x.
Jones RH, Lydeard SE, Hobbs FD, et al. Dyspepsia in England and Scotland. Gut. 1990;31:401–5. doi:10.1136/gut.31.4.401.
Agreus L, Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics. 2002;20:347–55. doi:10.2165/00019053-200220050-00006.
Graham DY, Adam E, Reddy GT, et al. Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci. 1991;36:1084–8. doi:10.1007/BF01297451.
Malaty HM. Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol. 2007;21:205–14. doi:10.1016/j.bpg.2006.10.005.
NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. JAMA. 1994;272:65–9. doi:10.1001/jama.272.1.65.
Working IARC. Group on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241.
Delaney B, Ford AC, Forman D, et al. Initial management strategies for dyspepsia. Initial management strategies for dyspepsia. Cochrane Database Syst Rev. 2005 Issue 4: CD001961.
Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006; issue 2: CD002096.
Bernersen B, Johnsen R, Straume B, et al. Towards a true prevalence of peptic ulcer: the Sorreisa gastrointestinal disorder study. Gut. 1990;31:989–92. doi:10.1136/gut.31.9.989.
Svedlund J, Sjodin I, Dotevall G. GSRS—a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33:129–34. doi:10.1007/BF01535722.
Dimenas E, Glise H, Hallerback B, et al. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol. 1995;30:1046–52. doi:10.3109/00365529509101605.
Bernersen B, Johnsen R, Straume B. Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors. Gut. 1996;38:822–5. doi:10.1136/gut.38.6.822.
Asfeldt AM, Lochen ML, Straume B, et al. Accuracy of a monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection. Scand J Gastroenterol. 2004;39:1073–7. doi:10.1080/00365520410007944.
World Health Organization, Ahmad OB, Boschi-Pinto C, Lopez AD, et al. Age standardization rates: a new who standard. GPE Discussion paper Series: No. 31: Hearings Before the SubComm. EIP/GPE/EBD of the House Comm, 2000.
Bernersen B. The Sørreisa Gastrointestinal Disorder Study. Dyspepsia, peptic ulcer and endoscopic findings in a population (dissertation). Tromsø, Norway: University of Tromsø; 1996.
Bernersen B, Johnsen R, Bostad L, et al. Is Helicobacter pylori the cause of dyspepsia? BMJ. 1992;304:1276–9.
Lane JA, Harvey RF, Murray LJ, et al. A placebo-controlled randomized trial of eradication of Helicobacter pylori in the general population: study design and response rates of the Bristol Helicobacter Project. Control Clin Trials. 2002;23:321–32. doi:10.1016/S0197-2456(01)00208-2.
Lund E, Kumle M, Braaten T, et al. External validity in a population-based national prospective study—the Norwegian Women and Cancer Study (NOWAC). Cancer Causes Control. 2003;14:1001–8. doi:10.1023/B:CACO.0000007982.18311.2e.
Banke L. Epidemiology of gastric ulcer. A preliminary study. Ugeskr Laeger. 1967;129:1705–10.
El Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004;19:643–54. doi:10.1111/j.1365-2036.2004.01897.x.
Talley NJ, Weaver AL, Tesmer DL, et al. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology. 1993;105:1378–86.
Choung RS, Locke GR, Schleck CD, et al. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol. 2007;102:1983–9. doi:10.1111/j.1572-0241.2007.01381.x.
Talley NJ, Zinsmeister AR, Schleck CD, et al. Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community. Gut. 1994;35:619–24. doi:10.1136/gut.35.5.619.
Wildner-Christensen M, Hansen JM, De Muckadell OB. Risk factors for dyspepsia in a general population: non-steroidal anti-inflammatory drugs, cigarette smoking and unemployment are more important than Helicobacter pylori infection. Scand J Gastroenterol. 2006;41:149–54. doi:10.1080/00365520510024070.
Dimenas E, Carlsson G, Glise H, et al. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl. 1996;221:8–13. doi:10.3109/00365529609095544.
Moayyedi P, Forman D, Braunholtz D, et al. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group. Am J Gastroenterol. 2000;95:1448–55. doi:10.1111/j.1572-0241.2000.2126_1.x.
Talley NJ, Quan C. Review article: Helicobacter pylori and nonulcer dyspepsia. Aliment Pharmacol Ther. 2002;16(Suppl 1):58–65. doi:10.1046/j.1365-2036.2002.0160s1058.x.
Rowland M, Daly L, Vaughan M, et al. Age-specific incidence of Helicobacter pylori. Gastroenterology. 2006;130:65–72. doi:10.1053/j.gastro.2005.11.004.
Granstrom M, Tindberg Y, Blennow M. Seroepidemiology of Helicobacter pylori infection in a cohort of children monitored from 6 months to 11 years of age. J Clin Microbiol. 1997;35:468–70.
Acknowledgements
We thank the personnel at the Gastroenterology Unit, University Hospital of North Norway, for help in H. pylori antigen testing. The study was jointly funded by EXTRA funds from the Norwegian Foundation for Health and Rehabilitation, National Association for Digestive Diseases, Northern Norway Regional Health Authority and the University of Tromsø.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Asfeldt, A.M., Straume, B., Steigen, S.E. et al. Changes in the prevalence of dyspepsia and Helicobacter pylori infection after 17 years: The Sørreisa gastrointestinal disorder study. Eur J Epidemiol 23, 625–633 (2008). https://doi.org/10.1007/s10654-008-9275-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-008-9275-x